Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-25-001596
Filing Date
2025-11-25
Accepted
2025-11-25 16:31:44
Documents
64
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e7052_10-k.htm   iXBRL 10-K 1460023
2 EXHIBIT 21.1 e7052_ex21-1.htm EX-21.1 4309
3 EXHIBIT 23.1 e7052_ex23-1.htm EX-23.1 3587
4 EXHIBIT 31.1 e7052_ex31-1.htm EX-31.1 17107
5 EXHIBIT 31.2 e7052_ex31-2.htm EX-31.2 15442
6 EXHIBIT 32.1 e7052_ex32-1.htm EX-32.1 7186
7 GRAPHIC image_001.jpg GRAPHIC 531034
8 GRAPHIC image_002.jpg GRAPHIC 38875
9 GRAPHIC image_003.jpg GRAPHIC 233210
10 GRAPHIC image_004.jpg GRAPHIC 39715
  Complete submission text file 0001731122-25-001596.txt   7129889

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE avxl-20250930.xsd EX-101.SCH 37320
12 XBRL CALCULATION FILE avxl-20250930_cal.xml EX-101.CAL 30135
13 XBRL DEFINITION FILE avxl-20250930_def.xml EX-101.DEF 108397
14 XBRL LABEL FILE avxl-20250930_lab.xml EX-101.LAB 328403
15 XBRL PRESENTATION FILE avxl-20250930_pre.xml EX-101.PRE 249914
66 EXTRACTED XBRL INSTANCE DOCUMENT e7052_10-k_htm.xml XML 652209
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 251521783
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)